QPW
BIO icon

Quantum Private Wealth’s Bio-Rad Laboratories Class A BIO Stock Holding History

Quantum Private Wealth’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-856
Closed -$325K – 183
2023
Q2 		$325K Buy
856
+52
+6% +$21.2K 0.15% 135
2023
Q1 		$385K Buy
804
+77
+11% +$36K 0.21% 112
2022
Q4 		$306K Sell
727
-396
-35% -$160K 0.19% 123
2022
Q3 		$468K Buy
+1,123
New +$560K 0.29% 89

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quantum Private Wealth's BIO Position: Q3 2023 in Review

Quantum Private Wealth sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2023, closing a stake of 856 shares — an estimated $325K sold.

Quantum Private Wealth first reported a position in BIO in Q3 2022 and held it in 4 quarters. The position peaked at $468K in Q3 2022. 467 funds tracked by Wall St. Rank hold BIO as of Q3 2023.

  • Quantum Private Wealth reported no remaining Bio-Rad Laboratories Class A position as of Q3 2023 after selling out during the quarter.
  • Quantum Private Wealth sold 856 Bio-Rad Laboratories Class A shares in Q3 2023, an estimated $325K.
  • Quantum Private Wealth first reported a position in Bio-Rad Laboratories Class A in Q3 2022 and held it in 4 quarters.
  • Quantum Private Wealth's Bio-Rad Laboratories Class A position peaked at $468K in Q3 2022.
  • 467 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2023.

Based on Quantum Private Wealth's 13F filing for Q3 2023, filed 2 Nov 2023.